BBTX — Bambusa Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 2044950 ·
Last close
$16.35
Market Cap
$832.91M
52W High
$17.65
52W Low
$13.60
ADV30
400,627
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 77,496,000 | 46,534,000 | 148,454,000 |
| Dec 2025 | — | — | — | — | 95,713,000 | 50,643,000 | 144,883,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-77,188,000
Inventory
—
Receivables
$1,226,000
ST Investments
$24,941,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -40,696,000 | -41,087,000 | 95,713,000 | 144,883,000 | -49,170,000 | -39,804,000 |
| Dec 2024 | 0 | -13,880,000 | -13,741,000 | 9,764,000 | 23,312,000 | -13,548,000 | -4,634,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MGTX | MeiraGTx Holdings plc | $826.80M | $8.46 | — |
| PRME | Prime Medicine, Inc. | $854.20M | $3.84 | — |
| GLUE | Monte Rosa Therapeutics, Inc. | $775.03M | $9.07 | — |
| ODTX | Odyssey Therapeutics, Inc. | $931.07M | $19.37 | — |
| AURA | Aura Biosciences, Inc. | $744.13M | $7.15 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.